![](https://www.ataxia.org/wp-content/uploads/2022/07/6946913449_a7bb50a760_o-1024x694-1-300x203.jpg)
A Potential Treatment for Universal Lowering of all Polyglutamine Disease Proteins
Written by Frida Niss Edited by Dr. Hayley McLoughlin One drug to treat them all: an approach using RNA interference to selectively lower the amount of mutant protein in all polyglutamine diseases. Work by a group in Poland shows initial success in Huntington’s Disease, DRPLA, SCA3/MJD, and SCA7 patient cells. Read More…